Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ADVR: BULLS AND BEARS! -- Ignore unavailable to you. Want to Upgrade?

To: OLD JAKE JUSTUS who wrote (5996)	5/15/1998 1:35:00 AM
From: JustMy2Cents	Read Replies (1) \| Respond to of 8902

Here is the March 31 press release for those who did not see it the first time. Please see message from Old Jake Justus. ********************************************************************** Argentina for HIV/HPV Studies Using Reticulose YONKERS, N.Y., March 31 /PRNewswire/ -- Advanced Viral Research Corp. (OTC Bulletin Board: ADVR) today announced that its flagship drug RETICULOSE, has received an Investigational New Drug (IND) number from the ANMAT, the FDA of Argentina, for final (phase 3) testing in patients infected with HIV and the Human Papilloma Virus (HPV). The studies under this IND number are the final step in the approval process in Argentina. HPV infection is a sexually transmitted disease of world-wide incidence that is the cause of genital warts and has been implicated as a cause of cervical cancer in women. Reticulose is a non-toxic immunomodulator that has been shown to have broad spectrum antiviral activity. Argentina is an important member of the Mercosur States, that include Bolivia, Brazil, Uruguay, Paraguay, and Chile. These countries have a combined population of approximately 250 million people, thus providing a potentially large market of RETICULOSE. "The granting of an IND number for the use of Reticulose in Argentina is an important event for the company," said Dr. Shalom Z. Hirschman, President and CEO of Advanced Viral Research Corp. "We expect that this will result in the approval to market Reticulose in Argentina for the treatment of HIV and HPV infected patients and to be followed with approvals by the other Mercosur States." NOTE: This news release contains forward-looking statements that involve risks and uncertainties, including risks associated with clinical development, regulatory approvals, including application to FDA, product commercialization and other risks described from time to time in the SEC reports filed by ADVR. RETICULOSE is not approved by the U.S. Food and Drug Administration or any comparable agency of any other countries. SOURCE Advanced Viral Research Corp. -0- 03/31/98 /CONTACT: Stephanie Brooks of SCIENS Worldwide Public Relations, 212-771-5518/ (ADVR)

To: OLD JAKE JUSTUS who wrote (5996)	5/17/1998 10:38:00 PM
From: OLD JAKE JUSTUS	Read Replies (1) \| Respond to of 8902

TO: ALL FOR INFORMATIONAL PURPOSES ONLY. This information should not be misconscrued as a solicitation to buy or sell shares of ADVR. Co:ADVR - ADVANCED VIRAL RSCH,$/share(US) Exchange:OTC MACROWORLD(tm) 7-DAY OUTLOOK 5/15/98 ------------------------------------------------------------ Latest Data: 5/15/98 closed at $0.39, unchanged. This is within the -0.02 average daily change. The daily model indicates that this is an exceptionally High $/share! ------------------------------------------------------------ 7-day Alert: "B" rating for a Decline (possible Short position). StopLoss at $0.44 (review any Long positions). - watch future reports for signal reversal - * $ 783K avg.daily volume too low for institutions. ------------------------------------------------------------ Forecast Summary: There is a 85% chance of being Lower in 7 days. Most likely 5/22/98 level is $0.31, a 19.9% -------------------------------------------------- \| 70% confidence range\| \| Forecast Closing --------------------\| \| Days $/share Change High Low \| \|------------------------------------------------\| \| 05/16/98 Sat \| \| 05/17/98 Sun \| \| 05/18/98 0.37 -0.02 0.39 0.35 \| \| 05/19/98 0.37 0.00 0.39 0.35 \| \| 05/20/98 0.35 -0.02 0.37 0.33 \| \| 05/21/98 0.35 0.00 0.37 0.33 \| \| 05/22/98 0.33 -0.02 0.35 0.31 \| -------------------------------------------------- Co:ADVR - ADVANCED VIRAL RSCH,$/share(US) Exchange:OTC MACROWORLD(tm) 5-WEEK OUTLOOK 5/15/98 ------------------------------------------------------------ Latest Week: 5/15/98 averaged $0.37, up 0.04. This is larger than the -0.02 average weekly change. The weekly model indicates that this is an exceptionally High $/share! ------------------------------------------------------------ 5-week Alert: * see Alert on 7day Outlook ** ------------------------------------------------------------ Forecast Summary: There is a 80% chance of being Lower in 5 weeks. Most likely 6/19/98 level is $0.35, a 10.3% decrease vs latest $0.39/share. -------------------------------------------------- \| 70% confidence range\| \| Forecast Average --------------------\| \| Week of $/share Change High Low \| \|------------------------------------------------\| \| 05/22/98 0.37 0.00 0.39 0.35 \| \| 05/29/98 0.35 -0.02 0.37 0.33 \| \| 06/05/98 0.34 -0.01 0.36 0.32 \| \| 06/12/98 0.36 0.02 0.38 0.34 \| \| 06/19/98 0.35 -0.01 0.37 0.33 \| -------------------------------------------------- However, the Daily model's outlook is Down. Co:ADVR - ADVANCED VIRAL RSCH,$/share(US) Exchange:OTC MACROWORLD(tm) 4-MONTH OUTLOOK 5/14/98 ------------------------------------------------------------ Latest Month: Apr'98 averaged $0.28, up 0.03. This is within the -0.05 average monthly change. ------------------------------------------------------------ 4-month Alert: * see Alert on 7day Outlook ** ------------------------------------------------------------ Forecast Summary: There is a 65% chance of being Higher in 4 months. Most likely Aug'98 level is $0.41, a 5.1% increase vs latest $0.39/share. -------------------------------------------------- \| 70% confidence range\| \| Forecast Average --------------------\| \| Months $/share Change High Low \| \|------------------------------------------------\| \| May'98 0.32 0.04 0.34 0.30 \| \| Jun'98 0.32 0.00 0.35 0.29 \| \| Jul'98 0.36 0.04 0.40 0.32 \| \| Aug'98 0.41 0.05 0.46 0.36 \| -------------------------------------------------- However, the Weekly model's outlook is Down.